GREM1 and neoplasm: Expression of VEGFR2 in HUVEC and HBMEC in vitro and in the DIPG tumor vasculature in vivo also supports the possibility that GREM-1 acting through VEGFR2 may modulate DIPG angiogenesis (Figure 6).